The global Rapid Sterility Testing Market Analysis is anticipated to have held a market value of USD 158 million in the year 2017 and is expected to grow at a CAGR of 13.4% during the forecast period. Rapid sterility testing used to detect microbial contamination in given biologic sample. It is an alternative method for sterility testing.
Increasing RD expense and new product launches are expected to drive the growth of the market. According to the Center for Drug Evaluation and Research, in 2017, about 46 novel drug approvals were the 22 novel drug approval in 2016. On the other hand, the availability of the alternative traditional method can restrain the market growth over the assessment period.
Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and growth in pharmaceutical and medical device companies. Europe is expected to hold the second largest position in the global market. Asia-Pacific is expected to be the fastest growing market owing to the increasing adoption of the technologies. Furthermore, the Middle Eastern and African region is expected to account for the least market share in the global market.
Access Report Details @ https://www.marketresearchfuture.com/reports/rapid-sterility-testing-market-6621
The global rapid sterility testing market has been segmented into product, technology, and application.
Based on product, the market is segmented into kits reagents, instruments, and services. The kits reagents segment is expected to account for the largest share and fastest growing segment of the global market in 2017.
Based on technology, the market is segmented into membrane filtration, ATP bioluminescence, and others. The ATP bioluminescence segment is expected to account for the largest share segment of the global market in 2017.
Based on application, has been segmented into pharmaceutical and biological manufacturing, medical device manufacturing, other end users.
Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/6621
Some of the prominent players in the global rapid sterility testing market are Charles River Laboratories, Inc. (US), Gibraltar Laboratories (US), Merck KGaA (Germany), Rapid Micro Biosystems, Inc. (US), bioMérieux (France), Eurofins Scientific (Luxembourg), Becton, Dickinson and Company (US), FOCUS Laboratories (US), Sartorius AG (Germany), and Thermo Fisher Scientific (US).